Share this article
Share this article
FLORHAM PARK, N.J. and GAITHERSBURG, Md., May 25, 2021 /PRNewswire/ Celularity, Inc. ( Celularity ), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta, and MaxCyte, Inc., a leading provider of cell-engineering platform technologies for next generation cell-based therapies, today announce the signing of a strategic platform license.
Celularity will obtain non-exclusive rights to use MaxCyte s Flow Electroporation
® technology and ExPERT™ platform enabling Celularity to accelerate the development of innovative, off the shelf allogeneic cell therapies, including genetically modified natural killer (NK) cell therapies and CAR T-cell therapies derived from the postpartum placenta. In return, MaxCyte is entitled to platform licensing fees and program-related milestone payments.
Share this article
Share this article
NEW YORK, May 14, 2021 /PRNewswire/ GX Acquisition Corp. ( GX ) (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve an amendment to GX s amended and restated certificate of incorporation to extend the date by which GX must effectuate its initial business combination from May 23, 2021 to July 31, 2021. As previously disclosed, on January 8, 2021, GX entered into a Merger Agreement and Plan of Reorganization (the Merger Agreement ) with Celularity Inc. ( Celularity ), Alpha First Merger Sub, Inc. and Alpha Second Merger Sub, LLC. Upon the terms and subject to the conditions of the Merger Agreement, Celularity will become a wholly owned subsidiary of GX. GX and Celularity are continuing to work together to address comments from the staff of the U.S. Securities and Exchange Commission ( SEC ) on the proxy statement/prospectus filed in connection with the transact
KUALA LUMPUR (May 11): Based on corporate announcements and news flow today, stocks in focus for tomorrow (May 12) may include the following: Malayan Banking Bhd, FGV Holdings Bhd, Pos Malaysia Bhd, WTK Holdings Bhd, Public Bank Bhd, Bina Darulaman Bhd, Careplus Group Bhd, JF Technology Bhd, Media Chinese International Ltd, and Genting Bhd.
Malayan Banking Bhd s (Maybank) 100%-owned subsidiary Maybank Islamic Bhd today announced the buy-back of RM1.5 billion worth of Islamic bonds via private treaty under the latter s Islamic commercial papers and medium term notes programme of up to RM10 billion.
FGV Holdings Bhd has appointed Azman Ahmad, who is the group divisional director of logistics & support business, as officer-in-charge to cover the duties and responsibilities of the group chief executive officer (CEO) effective May 16, 2021.
Share this article
Share this article
NEW YORK, May 10, 2021 /PRNewswire/ GX Acquisition Corp. ( GX ) (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX s amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the Extension and such later date, the Extended Date ). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021. The Extension will allow GX until the Extended Date to complete its initial business combination.
In order to support this proposal, GX has agreed that, if the Extension is approved, GX will deposit into the trust account $0.025 per share for each month of the Extension period, pro-rated for partial months during the Extension period, resulting in a maximum contribution of $0.0565 per share of Class A
Message :
Required fields
NEW YORK, May 10, 2021 /PRNewswire/ GX Acquisition Corp. ( GX ) (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX s amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the Extension and such later date, the Extended Date ). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021. The Extension will allow GX until the Extended Date to complete its initial business combination.
In order to support this proposal, GX has agreed that, if the Extension is approved, GX will deposit into the trust account $0.025 per share for each month of the Extension period, pro-rated for partial months during the Extension period, resulting in a maximum contribution of $0.0565 per share of Class A common stoc